- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
China moves into the lead in growth rate for PACS
Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.
Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.
The annual average PACS growth rate of 20% in China expected over the next five years is the highest in the world. The growth rate in Japan and South Korea is half that of China.
The surging interest seen in Asia presents new opportunities and challenges for multinational PACS manufacturers. To successfully participate in the region, PACS vendors must adapt their technology to meet specific characteristics demanded by each country.
China, Southeast Asia, and South Korea typically use radiology information and hospital information systems that do not comply with the U.S. HL7 standard. Instead, these countries opt for a variety of local language-based systems that operate on 2-bit characters.
On the other hand, the U.S. patient care model is already popular in areas such as Malaysia, Singapore, Australia, New Zealand, and Hong Kong.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
